# Escitalopram Plasma Concentrations in Premenopausal and Postmenopausal Women

> **NCT07259525** · — · NOT_YET_RECRUITING · sponsor: **Eskisehir Osmangazi University** · enrollment: 94 (estimated)

## Conditions studied

- Therapeutic Drug Monitoring (TDM)
- Menopause
- Depression - Major Depressive Disorder
- General Anxiety Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07259525
- **Lead sponsor:** Eskisehir Osmangazi University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2028-01
- **Final completion:** 2028-06
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2025-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07259525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07259525, "Escitalopram Plasma Concentrations in Premenopausal and Postmenopausal Women". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT07259525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*